Viatris (VTRS) Amortization - Goodwill (2023 - 2025)

Viatris (VTRS) recorded quarterly Amortization - Goodwill of $2.9 billion in Q1 2025, up 815.89% quarter-over-quarter from $321.0 million in Q2 2024.

Viatris (VTRS) Amortization - Goodwill (2023 - 2025) Analysis & Trends

Viatris' Amortization - Goodwill history runs 3 years deep, the most recent figure standing at $2.9 billion for Q1 2025.

  • In Q1 2025, Amortization - Goodwill changed N/A year-over-year to $2.9 billion; the TTM figure through Dec 2025 stood at $2.9 billion (up 815.89% YoY), while the FY2025 annual figure was $2.9 billion, up 814.89% from the prior year.
  • Amortization - Goodwill was $2.9 billion for Q1 2025 at Viatris, up from $321.0 million in the prior quarter.
  • In the past five years, Amortization - Goodwill ranged from a high of $2.9 billion in Q1 2025 to a low of $321.0 million in Q2 2024.
  • Historically, Amortization - Goodwill has averaged $1.3 billion across 3 years, with a median of $580.1 million in 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn
10 Viatris - - 1.16 Bn

Historic Data

Download Data
DateValue
Mar 31, 2025 2.94 Bn
Jun 30, 2024 321.00 Mn
Dec 31, 2023 580.10 Mn